Cited by 32Estrogen and related hormone effectsEndometrial and Cervical Cancer TreatmentsBreast Cancer Treatment Studies

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Aromatase cytochrome P450 gene expression in endometrial carcinoma

Open access
Sasano, H, Kaga, K, Sato, S, Yajima, A, Nagura, H, Harada, N·1996·British Journal of Cancer

Abstract

We analysed aromatase gene expression and its regulation in seven cases of endometrioid endometrial carcinoma. Immunohistochemistry revealed the presence of strong aromatase immunoreactivity in the stromal cells of carcinoma in five out of seven cases. A polymerase chain reaction after reverse transcription (RT PCR) revealed varying levels of aromatase transcripts (0.1-27.0 amol ng(-1) total mRNA) in five cases. The alternative use of multiple exons 1 was also examined by identifying various human aromatase transcripts specific for exons 1 in RT-PCR products. Gonadal type or exon 1d was primarily used in three cases in which aromatase overexpression was not detected. The two cases in which fibroblasts type or exon 1b was used with other exons 1 as minor transcripts demonstrated aromatase overexpression in immunohistochemistry and RT PCR analysis. Further studies are required, but alternative splicing as well as use of multiple exons 1 transcripts may result in increased aromatase expression in stromal cells observed in endometrial carcinoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/bjc.1996.586

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Increased immunoexpression of aromatase, STS and 17βHSD enzymes has been reported in endometrial hyperplasia and endometrial cancer.

    “Sasano and collaborators have developed novel antibodies and reported evidence of increased immunoexpression of aromatase [81], STS [82] and 17βHSD enzymes [83] in endometrial hyperplasia and EC.”

    From Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders (2018) · cites this paper as [81]

    The Results (Immunohistochemistry, p. 1543) report relatively strong aromatase immunoreactivity in five endometrial carcinoma cases. The paper does not report an immunohistochemical result for endometrial hyperplasia; its Methods say the antibody and staining procedures were described previously. STS and 17βHSD have separate citations in the citing sentence and are not attributed to this paper. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Sasano, H., Kaga, K., Sato, S., Yajima, A., Nagura, H., & Harada, N.
Affiliations
  • Tohoku University (JP)
  • Fujita Health University (JP)
Corresponding author
  • Sato, S
  • Nagura, H
Venue
British Journal of Cancer
Published
1996-11
Volume
74
Issue
10
Pages
1541-1544
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2058479118
Cited by
32
References
15
Citations by year
2021: 1 · 2018: 2 · 2015: 2 · 2014: 1 · 2013: 1
FWCI
1.00
Type
journal article
Language
en
Open access
Locations
  • British Journal of Cancer (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords
aromatase, endometrial cancer, endometrioid carcinoma, gene expression, alternative splicing, stromal cells, immunohistochemistry, RT-PCR
MeSH terms
Adult, Aged, Aromatase, Estrogens, Exons, Female, Humans, Immunohistochemistry, Middle Aged, RNA, Messenger, Sensitivity and Specificity, Transcription, Genetic, Gene Expression, Polymerase Chain Reaction, Endometrial Neoplasms, Alternative Splicing, Carcinoma, Endometrioid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review